X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
male (21) 21
child (20) 20
index medicus (19) 19
oncology (19) 19
female (17) 17
adolescent (13) 13
child, preschool (13) 13
pediatrics (10) 10
brain neoplasms - drug therapy (9) 9
brain tumors (8) 8
children (8) 8
infant (8) 8
clinical neurology (7) 7
radiation-therapy (7) 7
treatment outcome (7) 7
abstracts (6) 6
care and treatment (6) 6
chemotherapy (6) 6
medicine & public health (6) 6
medulloblastoma (6) 6
radiotherapy (6) 6
retrospective studies (6) 6
surgery (6) 6
young adult (6) 6
adult (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
central-nervous-system (5) 5
childhood (5) 5
hematology (5) 5
magnetic resonance imaging (5) 5
medulloblastoma - drug therapy (5) 5
prognosis (5) 5
article (4) 4
brain neoplasms - pathology (4) 4
brain-tumors (4) 4
medulloblastoma - radiotherapy (4) 4
neurosciences (4) 4
pathology (4) 4
patient outcomes (4) 4
radiation (4) 4
research (4) 4
temozolomide (4) 4
brain neoplasms - genetics (3) 3
brain neoplasms - radiotherapy (3) 3
brain neoplasms - surgery (3) 3
cancer in children (3) 3
carboplatin (3) 3
cerebellar neoplasms - pathology (3) 3
cerebellar neoplasms - radiotherapy (3) 3
childhood cancer (3) 3
dacarbazine - administration & dosage (3) 3
dacarbazine - analogs & derivatives (3) 3
diagnosis (3) 3
drug administration schedule (3) 3
follow-up studies (3) 3
glioma - drug therapy (3) 3
immunohistochemistry (3) 3
incidence (3) 3
infant, newborn (3) 3
middle aged (3) 3
neurosurgery (3) 3
pilocytic astrocytoma (3) 3
prognostic-factors (3) 3
radiation therapy (3) 3
radiotherapy dosage (3) 3
recurrent (3) 3
risk factors (3) 3
spinal cord (3) 3
therapy (3) 3
tumor (3) 3
tumors (3) 3
vincristine (3) 3
vincristine - administration & dosage (3) 3
abnormalities (2) 2
acute lymphoblastic-leukemia (2) 2
analysis of variance (2) 2
animals (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
astrocytoma - drug therapy (2) 2
bevacizumab (2) 2
brain neoplasms - therapy (2) 2
cancer (2) 2
carboplatin - administration & dosage (2) 2
case studies (2) 2
central nervous system neoplasms - drug therapy (2) 2
central nervous system tumors (2) 2
cerebellar neoplasms - drug therapy (2) 2
chromosome deletion (2) 2
chromosomes, human, pair 22 (2) 2
combined modality therapy (2) 2
cranial irradiation - adverse effects (2) 2
dacarbazine - therapeutic use (2) 2
disease progression (2) 2
disease-free survival (2) 2
dissemination (2) 2
dosage and administration (2) 2
drug therapy (2) 2
entity (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 94, Issue 1, pp. 133 - 138
Journal Article
Neuro-Oncology, ISSN 1522-8517, 06/2018, Volume 20, Issue suppl_2, pp. i162 - i162
Abstract BACKGROUND Brain tumors (BTs) have the highest mortality rate of all pediatric neoplasms. Patients with BTs have distinct constellations of symptoms... 
Abstracts
Journal Article
Neuro-Oncology, ISSN 1522-8517, 06/2018, Volume 20, Issue suppl_2, pp. i165 - i165
Abstract Treatment with cranial irradiation increases the risk for ACTH deficiency (ACTH-D). Screening for ACTH-D is controversial due to lack of an ideal... 
Abstracts
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 01/2016, Volume 94, Issue 1, pp. 133 - 138
Purpose The purpose of this study was to compare long-term disease control and overall survival between children treated with proton and photon radiation... 
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 1, pp. 106 - 112
Purpose To investigate the incidence, risks, severity, and sequelae of posterior fossa syndrome (PFS) in children with medulloblastoma. Methods and Materials... 
Radiology | Hematology, Oncology and Palliative Medicine | Posterior fossa syndrome | Medulloblastoma | Cerebellar mutism syndrome | Posterior fossa surgery | SURGERY | PROGNOSTIC-FACTORS | RESECTION | TUMOR | RADIATION | ADULT | PATHOPHYSIOLOGY | TRANSIENT CEREBELLAR MUTISM | ONCOLOGY | DYSARTHRIA | CHILDRENS CANCER GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Muscle Hypotonia - epidemiology | Follow-Up Studies | Humans | Ataxia - etiology | Child, Preschool | Male | Risk | Dysarthria - epidemiology | Incidence | Muscle Hypotonia - etiology | Neoplasm, Residual | Young Adult | Mutism - etiology | Medulloblastoma - radiotherapy | Mutism - epidemiology | Medulloblastoma - pathology | Female | Medulloblastoma - surgery | Retrospective Studies | Cerebellar Neoplasms - pathology | Child | Radiotherapy Dosage | Cerebellar Neoplasms - drug therapy | Dysarthria - etiology | Postoperative Complications - epidemiology | Ataxia - epidemiology | Cranial Irradiation | Syndrome | Disease-Free Survival | Analysis of Variance | Adolescent | Combined Modality Therapy - methods | Cerebellar Neoplasms - surgery | Medulloblastoma - drug therapy | Cerebellar Neoplasms - radiotherapy | ANIMALS | NEOPLASMS | NERVOUS SYSTEM | CENTRAL NERVOUS SYSTEM | MEDICINE | PRIMATES | CHEMOTHERAPY | NUCLEAR MEDICINE | CHILDREN | ORGANS | HEALTH HAZARDS | DISEASES | THERAPY | VERTEBRATES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | MAN | AGE GROUPS | BODY | BRAIN | RADIOLOGY | HAZARDS | MAMMALS
Journal Article
Neuro-Oncology, ISSN 1522-8517, 06/2018, Volume 20, Issue suppl_2, pp. i67 - i67
Abstract A 2 month old child with a large hemispheric tumor; after subtotal resection, pathology showed pilomyxoid astrocytoma with BRAFV600E mutation by... 
Abstracts
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2018, Volume 20, Issue suppl_6, pp. vi201 - vi201
Abstract BACKGROUND Polyinosinic-Polycytidylic acid stabilized with polylysine and carboxymethylcellulose (poly-ICLC) is a double stranded RNA that acts as a... 
Abstracts
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2005, Volume 23, Issue 30, pp. 7621 - 7631
Journal Article
Neuro-Oncology, ISSN 1522-8517, 06/2018, Volume 20, Issue suppl_2, pp. i116 - i117
Abstract Low dose Poly-ICLC (Polyinosinic-Polycytidylic acid stabilized with polylysine and carboxymethylcellulose) has a direct immune enhancing action... 
Abstracts
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2019, Volume 21, Issue Supplement_6, pp. vi183 - vi184
Abstract BACKGROUND/OBJECTIVE Survival had been poor in several multi-center/national studies since the 1980s attempting to delay, avoid or minimize brain... 
Journal Article
Pediatric Neurology, ISSN 0887-8994, 12/2019, Volume 101, pp. 2 - 10
Journal Article
Cancer, ISSN 0008-543X, 10/2007, Volume 110, Issue 7, pp. 1542 - 1550
BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against... 
Central nervous system tumors | Phase 2 trials | Imidazotetrazine | Temozolomide | Brain tumors | Childhood cancer | temozolomide | GLIOBLASTOMA-MULTIFORME | II TRIAL | imidazotetrazine | BRAIN-TUMORS | RADIATION-THERAPY | MALIGNANT GLIOMA | phase 2 trials | brain tumors | ANTITUMOR IMIDAZOTETRAZINES | ONCOLOGY | central nervous system tumors | PEDIATRIC-PATIENTS | O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | DNA METHYLTRANSFERASE | childhood cancer | HIGH-GRADE GLIOMA | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Child, Preschool | Neoplasm Recurrence, Local - drug therapy | Infant | Male | Antineoplastic Agents, Alkylating - administration & dosage | Ependymoma - drug therapy | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Adult | Female | Child | Dacarbazine - administration & dosage | Drug Administration Schedule | Administration, Oral | Treatment Outcome | Brain Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Adolescent | Antineoplastic Agents, Alkylating - adverse effects | Medulloblastoma - drug therapy | Central Nervous System Neoplasms - drug therapy | Relapse | Care and treatment | Demographic aspects | Nervous system tumors | Patient outcomes | Dosage and administration | Research | Drug therapy | Cancer in children | Cancer
Journal Article